How novel antibody felzartamab impacts IgA nephropathy? Dr. Kamal Kant Kohli3 Feb 2025 8:30 PM ISTIgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase 2...
Study elaborates clinical significance of microvascular inflammation after kidney transplantation Dr. Kamal Kant Kohli3 Nov 2024 8:15 PM ISTInvestigators recently uncovered key insights into newly defined rejection entities in kidney transplantation that may offer improved patient risk...
Which are High-impact clinical trials that may generate promising results for improving kidney health? Dr Kartikeya Kohli1 Nov 2024 8:00 PM ISTThe results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney...
SGLT2 inhibitor canagliflozin has Heart and kidney benefits among patients across all age categories: Study Dr Kartikeya Kohli28 Oct 2024 8:30 PM ISTSodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is...
International Consensus Statement on Chronic Kidney Disease and Global Public Health Agenda Published Dr. Kamal Kant Kohli19 April 2024 10:00 AM ISTNature Reviews Nephrology published a landmark international consensus statement titled "Chronic Kidney Disease and the Global Public Health Agenda:...
Elevated urinary albumin tied to sub-clinical cardiovascular disease in diabetes patients Dr. Kamal Kant Kohli26 Jan 2024 1:45 AM ISTDenmark: A recent study revealed that elevated albumin in the urine may be linked with sub-clinical coronary artery pathology, including coronary...
Aprocitentan effective for BP lowering in patients with CKD and resistant hypertension Medha Baranwal10 Jan 2024 5:30 PM ISTUSA: Treatment with aprocitentan (APRO) showed safety and efficacy in patients with stage 3 or 4 chronic kidney disease (CKD), according to a subgroup...
AI-based algorithm predicts serious kidney-related complications after hospitalization: Study Dr. Kamal Kant Kohli23 Dec 2022 8:15 PM ISTFlorida: Serious kidney-related complications-or major adverse kidney events are common after hospitalization for various medical problems....
Atrasentan reduces triglycerides, albuminuria, and LDL-C in patients with type 2 diabetes and CKD Medha Baranwal8 Dec 2022 8:00 PM ISTNetherlands: In high-risk patients with type 2 diabetes (T2D) and CKD (chronic kidney disease), atrasentan provides cardioprotection, is the...
RAAS and SGLT2 Inhibitor combo increases survival in Patients with Albuminuric CKD without Diabetes Dr. Kamal Kant Kohli24 Nov 2022 8:00 PM ISTWashington: About half of patients with CKD do not have diabetes but experience high rates of kidney failure and early death. These patients are...
Pantoprazole causes Higher Rate of estimated GFR Decline compared to Placebo Dr. Kamal Kant Kohli9 Nov 2022 11:00 AM ISTCANADA: Compared to placebo, pantoprazole caused a faster rate of eGFR reduction. According to a study published in the American Society of...
Long-term exposure to air pollution can heighten kidney disease risk Isra Zaman5 Nov 2022 9:00 AM ISTAmong adults with normal kidney function, exposure to higher concentrations of components of air pollution was linked with higher risks of later...
